Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last €29.06 EUR
Change Today +0.005 / 0.02%
Volume 172.0
LDU On Other Exchanges
New York
As of 10:15 AM 05/5/15 All times are local (Market data is delayed by at least 15 minutes).

landauer inc (LDU) Snapshot

Previous Close
Day High
Day Low
52 Week High
05/28/14 - €35.85
52 Week Low
02/2/15 - €24.71
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for LANDAUER INC (LDU)

Related News

No related news articles were found.

landauer inc (LDU) Related Businessweek News

No Related Businessweek News Found

landauer inc (LDU) Details

Landauer, Inc., together with its subsidiaries, provides technical and analytical services, outsourced medical physics services, and radiology related medical products Worldwide. The company operates in three segments: Radiation Measurement, Medical Physics, and Medical Products. The Radiation Measurement segment provides analytical services to determine occupational and environmental radiation exposure; manufactures various radiation detection monitors; and distributes and collects monitors to and from customers, as well as analyzes and reports exposure findings. It also sells dosimetry detectors and reading equipment. This segment provides its services primarily to hospitals, medical and dental offices, universities, national laboratories, nuclear facilities, and other industries. The Medical Physics segment offers therapeutic and imaging physics services comprising clinical physics support, equipment commissioning, accreditation support, and imaging equipment testing to hospitals, radiation therapy centers, and imaging centers. The Medical Products segment provides medical consumable accessories that are used in radiology, radiation therapy, and image guided surgery procedures. It products include consumables used with MRI, CT, and mammography technologies; and passive reflective markers used during image guided surgery procedures. The company was founded in 1954 and is based in Glenwood, Illinois.

600 Employees
Last Reported Date: 02/3/15
Founded in 1954

landauer inc (LDU) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $59.8K
Vice President of Strategic Marketing & Produ...
Total Annual Compensation: $247.2K
President of Radiation Measurement
Total Annual Compensation: $350.0K
Total Annual Compensation: $252.9K
Compensation as of Fiscal Year 2014.

landauer inc (LDU) Key Developments

Landauer Inc. Announces Executive and Management Changes

Landauer Inc. announced that Dan Fujii will transition to the role of Chief Financial Officer and Secretary, effective April 15, 2015. As planned, Interim Chief Financial Officer Mark Zorko will transition back into an advisory role. Mr. Zorko joined Landauer in April of 2014 to assist with the resolution of accounting issues identified in the company. In addition, he has led several special projects in the financial division. Mr. Zorko will continue on with the company in the short term reporting to the CEO in a non-officer role completing special projects. Dan Fujii has been working closely with Mark Zorko the past few months to ensure a smooth transition and will assume the role of permanent Chief Financial Officer and Secretary, effective April 15, 2015. Mr. Fujii joined the company in April 2014 as Vice President, Corporate Controller with the goal of improving the strength of the financial function within Landauer. In addition, Kara Venegas has been promoted to the role of Vice President, Corporate Controller and Chief Accounting Officer, effective April 15, 2015. Ms. Venegas started with Landauer in June 2014 as Assistant Corporate Controller. Prior to Landauer, Kara was the accounting manager for Actient Pharmaceuticals and has seven years of experience in various public accounting roles. Ms. Venegas is a Certified Public Accountant and is currently near completion of a master's degree in accounting from DePaul University.

Landauer, Inc. Appoints Jeffrey Bailey as Independent Director

Landauer Inc. announced the appointment of Jeffrey Bailey as an independent director, effective April 15, 2015. Mr. Bailey has nearly 30 years of experience in the pharmaceutical industry with a broad range of functional leadership experience. Since 2013, he has been the president and chief executive officer and a director of Lantheus Medical Imaging Inc., Prior experiences include chief operating officer of Fougera Pharmaceuticals (formerly Nycomed US), chief commercial officer of King-Pfizer Pharmaceuticals, president and general manager of Novartis NorthWest Operating Unit and various executive, commercial and manufacturing roles within the Johnson & Johnson family of companies.

Landauer Inc. Seeks Acquisitions

Michael Leatherman, Chief Executive Officer of Landauer Inc. said that small, tuck-in, bolt-on and strategic acquisitions will help company to grow more quickly.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
LDU:GR €29.06 EUR +0.005

LDU Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Alphatec Holdings Inc $1.31 USD -0.03
Globus Medical Inc $23.51 USD -0.35
NuVasive Inc $46.65 USD +0.99
Orthofix International NV $32.21 USD -0.36
View Industry Companies

Industry Analysis


Industry Average

Valuation LDU Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 2.0x
Price/Book 31.6x
Price/Cash Flow NM Not Meaningful
TEV/Sales 1.1x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact LANDAUER INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at